Topical Formulation for a Jak Inhibitor
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 9 of these applications claim priority to application 14/714,820, filed May 18, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,758,543 | Topical Formulation for a Jak Inhibitor In force · High confidence UsedRemaining | Incyte Holdings Corporation | In force | High confidence | ||
| US 10,869,870 | Topical Formulation for a Jak Inhibitor In force · High confidence | Incyte Holdings Corporation | In force | High confidence | ||
| US 11,219,624 | Topical Formulation for a Jak Inhibitor In force · High confidence | Incyte Holdings Corporation | In force | High confidence | ||
| US 11,571,425 | Topical Formulation for a Jak Inhibitor In force · High confidence | Incyte Corporation | In force | High confidence | ||
| US 11,590,136 | Topical Formulation for a Jak Inhibitor In force · High confidence | Incyte Holdings Corporation | In force | High confidence | ||
| US 12,226,419 | Topical Formulation for a Jak Inhibitor In force · High confidence | Incyte Corporation | In force | High confidence | ||
| US 12,544,381 | Topical Formulation for Jak Inhibitor In force · High confidence | Incyte Holdings Corporation | In force | High confidence | ||
| US 12,564,593 | Topical Formulation for a Jak Inhibitor In force · High confidence | Incyte Holdings Corporation | In force | High confidence | ||
| US 12,622,908 | Topical Formulation for a Jak Inhibitor In force · High confidence | Incyte Holdings Corporation | In force | High confidence | ||
| Application 13/112,370 | Topical Formulation for a Jak Inhibitor Abandoned Abandoned Jul 20, 2015 | Incyte Holdings Corporation and Incyte Corporation | Abandoned | Abandoned Jul 20, 2015 | ||
| 3 more records in this group · Pro | ||||||
10 of 13 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 13.
9 of these are in force and held by Incyte Corporation.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.